
PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH
Keywords: بیماری کبدی چرب; Microparticles; Atherosclerosis; Fatty liver disease; Pharmacology; Murine model;